Beijing Tiantan Biological Products Co., Ltd. announced earnings guidance for the first half of 2019. For the period, the company predicts that its net profit belonging to shareholders of the listed company will be about RMB 297,805,400, with an increase of about 23.94% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be about RMB 297,097,100, with an increase of about 25.16% compared with the same period of the year before.